Final-Program-ATS-2023-AP.vp

292

TUESDAY • MAY 23

3:03 (P_2.5 - ) induced DNA Methylation Alterations in Patients With Fibrotic Interstitial Lung Disease/ G.C. Goobie, Vancouver, Canada 3:15 MMP-7 Mediates PM2.5 and Mortality Associations in Patients With Idiopathic Pulmonary Fibrosis/ S.E. Kim, Pittsburgh, PA 3:27 Long-term Exposure to Air Pollution and Lung Function in Cystic Fibrosis/ J. Cogen, Seattle, WA 3:39 Racial and Ethnic Disparities in Antifibrotic Therapy in Idiopathic Pulmonary Fibrosis/ J. Fares, Philadelphia, PA 3:51 Does Antacid Therapy in Idiopathic Pulmonary Fibrosis Patients Increase Risk of Pneumonia? An Observational Cohort Study/ G. Massen, London, United Kingdom Featured Speaker: 4:03 Environment and ILD: Tying It All Together/ K.A.M. Johannson, Calgary, Canada

2:39 Early Vs Late Initiation of Vasopressors in Sepsis: An Augmented Inverse Probability Weighting Approach/ D.C. Marshall, London, United Kingdom 2:51 Does the Approach to Administration of Norepinephrine Matter? A Comparison of Weight-based Versus Non-weight-based Dosing in Patients With Septic Shock/ O. Haun De Oliveira, Toronto, Canada 3:03 Patterns of Vasopressor Delivery and Potential for Reduction in Central Venous Catheter Use/ B. Teja, Toronto, Canada 3:15 Premorbid Metabolic Syndrome Is Associated With the Hypoinflammatory Latent Class Analysis (LCA) Phenotype in Acute Respiratory Distress Syndrome (ARDS) and Sepsis/ A.M. Bogart, Nashville, TN 3:27 Identifying Potentially Preventable Death From Sepsis/ E. Munroe, Ann Arbor, MI 3:39 Effect of Automated Real-time Feedback on Early Sepsis Care - A Cluster Randomized Study/ D. Leisman, Boston, MA 3:51 Machine Learning Methods to Address Confounding in Sepsis Mortality Rate/ T. Basu, Ann Arbor, MI 4:03 Human Induced Pluripotent Stem Cell Microvascular Organoid Model of Endothelial Dysfunction in Sepsis/ M.R. Atreya, Cincinnati, OH

BEHAVIORAL • CLINICAL • TRANSLATIONAL MINI SYMPOSIUM

C96

THE SCIENCE AND CLINICAL PRACTICE OF PULMONARY REHABILITATION

2:15 p.m. - 4:15 p.m.

Walter E. Washington Convention Center Room 204 A-C (Level 2)

BASIC • CLINICAL • TRANSLATIONAL MINI SYMPOSIUM

Chairing: C. Burtin, PT, PhD, Diepenbeek, Belgium A. Burge, PhD, Melbourne, Australia Oral Presentations: 2:15 Pulmonary Rehabilitation After Severe Exacerbations of COPD: A Nationwide Population Study/ M. Guecamburu, Pessac, France 2:27 Exercise Self-efficacy Barriers to Target for Clinically Meaningful Physical Activity Improvements in COPD/ S.A. Robinson, Bedford, MA 2:39 Computer Aided Lung Sound Analysis to Detect Acute Effects of Airway Clearance Techniques in Patients With Cystic Fibrosis/ E. Lauwers, Wilrijk, Belgium 2:51 Chronotropic Index and Heart Rate Response on Cardiopulmonary Exercise Testing in Patients With Advanced Lung Disease/ D. Shah, New Hyde Park, NY 3:03 Poor Exercise Capacity and Physical Function in Patients Awaiting Lung Cancer Surgery/ C.L. Granger, Melbourne, Australia 3:15 Effects of High Frequency Chest Wall Oscillation (HFCWO) on Clinical Symptoms in COPD/ M. Bruner, Birmingham, AL

C95

NOT JUST GENES: ENVIRONMENTAL EXPOSURES AND INTERSTITIAL LUNG DISEASE

2:15 p.m. - 4:15 p.m. Walter E. Washington Convention Center Ballroom B (Level 3) Chairing: K.A.M. Johannson, MD, MPH, ATSF, Calgary, Canada R.M. Tighe, MD, ATSF, Durham, NC G.C. Goobie, MD, PhD, Vancouver, Canada Oral Presentations: 2:15 Interstitial Lung Abnormalities Are Associated With Increased Mortality in PRISm/ S. Kalra, Boston, MA 2:27 The Impact of Occupational Exposures on the Risk of Idiopathic Pulmonary Fibrosis - A Systematic Review and Meta-analysis/ S. Gandhi, San Francisco, CA 2:39 Occupational Exposures and Interstitial Lung Abnormalities and Disease in World Trade Center Workers and Volunteers/ J. Johnson-Crooks, New York, NY 2:51 Screening for Beryllium Among U.S. Veterans With Sarcoidosis, 2002-2020/ M.I. Seedahmed, San Fransisco, CA

ATS 2023 • Washington, DC